Compare ELTK & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELTK | CBUS |
|---|---|---|
| Founded | 1970 | 2010 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Agricultural Chemicals |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.5M | 69.9M |
| IPO Year | 1997 | 2017 |
| Metric | ELTK | CBUS |
|---|---|---|
| Price | $9.20 | $2.09 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 3.1K | ★ 380.9K |
| Earning Date | 03-10-2026 | 03-19-2026 |
| Dividend Yield | ★ 2.25% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.17 | N/A |
| Revenue | ★ $49,310,000.00 | $3,794,000.00 |
| Revenue This Year | $18.60 | N/A |
| Revenue Next Year | $9.04 | $106.72 |
| P/E Ratio | $49.00 | ★ N/A |
| Revenue Growth | ★ 2.54 | N/A |
| 52 Week Low | $7.65 | $1.09 |
| 52 Week High | $12.19 | $3.40 |
| Indicator | ELTK | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 55.81 | 55.21 |
| Support Level | $8.55 | $2.05 |
| Resistance Level | $9.10 | $2.31 |
| Average True Range (ATR) | 0.47 | 0.23 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 81.47 | 65.22 |
Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. It manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnect, flex-rigid and multi-layered boards. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. Its geographic areas are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.